149 related articles for article (PubMed ID: 27867156)
1. Transcriptional Analysis of Intravenous Immunoglobulin Resistance in Kawasaki Disease Using an Induced Pluripotent Stem Cell Disease Model.
Ikeda K; Mizoro Y; Ameku T; Nomiya Y; Mae SI; Matsui S; Kuchitsu Y; Suzuki C; Hamaoka-Okamoto A; Yahata T; Sone M; Okita K; Watanabe A; Osafune K; Hamaoka K
Circ J; 2016 Dec; 81(1):110-118. PubMed ID: 27867156
[TBL] [Abstract][Full Text] [Related]
2. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.
Xie T; Wang Y; Fu S; Wang W; Xie C; Zhang Y; Gong F
Pediatr Rheumatol Online J; 2017 Mar; 15(1):17. PubMed ID: 28320400
[TBL] [Abstract][Full Text] [Related]
3. Transcript abundance patterns in Kawasaki disease patients with intravenous immunoglobulin resistance.
Fury W; Tremoulet AH; Watson VE; Best BM; Shimizu C; Hamilton J; Kanegaye JT; Wei Y; Kao C; Mellis S; Lin C; Burns JC
Hum Immunol; 2010 Sep; 71(9):865-73. PubMed ID: 20600450
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional regulation by infliximab therapy in Kawasaki disease patients with immunoglobulin resistance.
Ogihara Y; Ogata S; Nomoto K; Ebato T; Sato K; Kokubo K; Kobayashi H; Ishii M
Pediatr Res; 2014 Sep; 76(3):287-93. PubMed ID: 24964229
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients.
Sato S; Kawashima H; Kashiwagi Y; Hoshika A
Int J Rheum Dis; 2013 Apr; 16(2):168-72. PubMed ID: 23773640
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease.
Wang Y; Wang W; Gong F; Fu S; Zhang Q; Hu J; Qi Y; Xie C; Zhang Y
Arthritis Rheum; 2013 Mar; 65(3):805-14. PubMed ID: 23440694
[TBL] [Abstract][Full Text] [Related]
7. Expression of receptor for advanced glycation end products (RAGE) on the surface of circulating endothelial cells is upregulated in Kawasaki disease.
Gong F; Zhang Y; Xie C; Zhu W; Wang W; Fu S; Shen H
Pediatr Res; 2012 Jun; 71(6):720-4. PubMed ID: 22337222
[TBL] [Abstract][Full Text] [Related]
8. Functional benefits of corticosteroid and IVIG combination therapy in a coronary artery endothelial cell model of Kawasaki disease.
Inoue T; Murakami S; Matsumoto K; Matsuda A
Pediatr Rheumatol Online J; 2020 Oct; 18(1):76. PubMed ID: 33023630
[TBL] [Abstract][Full Text] [Related]
9. Relationship between T-cell HLA-DR expression and intravenous immunoglobulin treatment response in Kawasaki disease.
Wakiguchi H; Hasegawa S; Suzuki Y; Kudo K; Ichiyama T
Pediatr Res; 2015 Apr; 77(4):536-40. PubMed ID: 25580740
[TBL] [Abstract][Full Text] [Related]
10. Verification of risk scores to predict i.v. immunoglobulin resistance in incomplete Kawasaki disease.
Kanamitsu K; Kakimoto H; Shimada A; Nakata Y; Ochi H; Watanabe H; Iwasaki Y; Tokorodani C; Kanazawa A; Maruyama H; Miyazawa M; Nishiuchi R; Kikkawa K
Pediatr Int; 2016 Feb; 58(2):146-51. PubMed ID: 26190225
[TBL] [Abstract][Full Text] [Related]
11. Monocyte-Derived Interleukin-1β As the Driver of S100A12-Induced Sterile Inflammatory Activation of Human Coronary Artery Endothelial Cells: Implications for the Pathogenesis of Kawasaki Disease.
Armaroli G; Verweyen E; Pretzer C; Kessel K; Hirono K; Ichida F; Okabe M; Cabral DA; Foell D; Brown KL; Kessel C
Arthritis Rheumatol; 2019 May; 71(5):792-804. PubMed ID: 30447136
[TBL] [Abstract][Full Text] [Related]
12. Plasma Prostaglandin E2 Levels Correlated with the Prevention of Intravenous Immunoglobulin Resistance and Coronary Artery Lesions Formation via CD40L in Kawasaki Disease.
Kuo HC; Wang CL; Yang KD; Lo MH; Hsieh KS; Li SC; Huang YH
PLoS One; 2016; 11(8):e0161265. PubMed ID: 27525421
[TBL] [Abstract][Full Text] [Related]
13. Risk factors of immunoglobulin resistance and coronary complications in children with Kawasaki disease.
Berdej-Szczot E; Małecka-Tendera E; Gawlik T; Firek-Pędras M; Szydłowski L; Gawlik A
Kardiol Pol; 2017; 75(3):261-266. PubMed ID: 27995598
[TBL] [Abstract][Full Text] [Related]
14. [Effects of intravenous immunoglobulin upon the overexpression and over-activation of nuclear factor-κB and matrix metalloproteinase-9 in murine model of Kawasaki disease].
Shangguan W; Du Z; Yang H; Zhang Y; Song M; Dong W
Zhonghua Yi Xue Za Zhi; 2014 Apr; 94(12):938-43. PubMed ID: 24854917
[TBL] [Abstract][Full Text] [Related]
15. Fine specificities of natural regulatory T cells after IVIG therapy in patients with Kawasaki disease.
Burns JC; Touma R; Song Y; Padilla RL; Tremoulet AH; Sidney J; Sette A; Franco A
Autoimmunity; 2015 May; 48(3):181-8. PubMed ID: 25822882
[TBL] [Abstract][Full Text] [Related]
16. Marker of T-cell activation is elevated in refractory Kawasaki disease.
Suzuki H; Suenaga T; Takeuchi T; Shibuta S; Yoshikawa N
Pediatr Int; 2010 Oct; 52(5):785-9. PubMed ID: 20487370
[TBL] [Abstract][Full Text] [Related]
17. Low FCMR mRNA expression in leukocytes of patients with Kawasaki disease six months after disease onset.
Chang LS; Guo MM; Yan JH; Huang YH; Lo MH; Kuo HC
Pediatr Allergy Immunol; 2020 Jul; 31(5):554-559. PubMed ID: 32073687
[TBL] [Abstract][Full Text] [Related]
18. Exploring the relationship between pyroptosis, infiltrating immune cells and Kawasaki disease with resistance to intravenous immunoglobulin (IVIG) via bioinformatic analysis.
Xie Y; Han B
Immunobiology; 2022 Sep; 227(5):152261. PubMed ID: 36029669
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of TLR2, 3, 9 and Signaling Mediators, MyD88 and TRIF, Gene Transcript Levels in Patients with Kawasaki Disease Treated with IVIG.
Mortazavi SH; Amin R; Alyasin S; Kashef S; Karimi MH; Babaei M; Younesi V
Iran J Allergy Asthma Immunol; 2015 Apr; 14(2):188-97. PubMed ID: 25780885
[TBL] [Abstract][Full Text] [Related]
20. Serum Tenascin-C as a Novel Predictor for Risk of Coronary Artery Lesion and Resistance to Intravenous Immunoglobulin in Kawasaki Disease - A Multicenter Retrospective Study.
Okuma Y; Suda K; Nakaoka H; Katsube Y; Mitani Y; Yoshikane Y; Ichida F; Matsushita T; Shichino H; Shiraishi I; Abe J; Hiroe M; Yoshida T; Imanaka-Yoshida K
Circ J; 2016 Oct; 80(11):2376-2381. PubMed ID: 27746411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
